[LABD] Direxion Daily S&P Biotech Bear 3X ETF

Overview

Type of security: Fund

Tags: Biotech, Equity, Health care, Inverse, Inverse 3X

The data is delayed by 15 minutes.

 

Price: 16.89 Change: -1.99 (-10.54%)
Ext. hours: 16.88 Change: -0.01 (-0.06%)

chart LABD

Refresh chart

Strongest Trends Summary For LABD

LABD is in the medium-term down -51% in 3 weeks. In the long-term down -92% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Technical Data
High 52 week59.04 Low 52 week21.52 Last close28.7 Last change-1.2%
RSI37.6 Average true range6.26 Beta-4.51 Volume4.08 M
Simple moving average 20 days-31.12% Simple moving average 50 days-24.92% Simple moving average 200 days-5.94%
Performance Data
Performance Week-30.1% Performance Month-19.98% Performance Quart-3.24% Performance Half27.85%
Performance Year-36.21% Performance Year-to-date-32.91% Volatility daily9.72% Volatility weekly21.74%
Volatility monthly44.56% Volatility yearly154.35% Relative Volume215.56% Average Volume2.15 M
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap Number of holdings
Price to Book Value Price to Earnings Total expense ratio Total net assets
Weighted market capitalization

News

2019-01-14 10:05:37 | This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders

2018-12-21 10:58:03 | 7 Inverse ETFs That Soared More Than 70% in Q4

2018-11-13 15:57:45 | The Time Could Be Right For This Biotech ETF

2018-10-09 11:59:03 | 7 Leveraged/Inverse ETFs Off to a Strong Start in October

2018-08-31 09:12:41 | How the Biotech Sector Has Fared this Year

2018-07-18 12:27:43 | Exploring The Leveraged ETF Trade Heading Into Earnings Season

2018-03-28 11:43:17 | For Now, Traders Endorse Biotech Rally

2018-02-28 16:30:00 | Direxion Announces Reverse Splits of Five ETFs

2017-11-29 16:46:23 | Short Interest And Leveraged ETFs

2017-11-15 13:18:00 | How venture philanthropy is helping to find a diabetes cure

2017-11-14 15:49:03 | Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate

2017-11-14 14:13:00 | GE made a mistake slashing its dividend, and the entire Dow is paying the price today: NYSE trader

2017-11-14 10:33:00 | Yellen, Draghi, Carney and Kuroda met in Frankfurt today—here's what went down

2017-11-13 13:45:00 | The biggest market-mover this week is the 'argy bargy' on taxes down in the Beltway: NYSE trader

2017-11-10 11:05:00 | Nvidia and Intel are set to be long-term market leaders

2017-11-10 10:55:00 | Stocks have bigger problems than tax reform

2017-11-09 17:20:00 | 3 signs the bulls are still kicking

2017-11-06 11:10:00 | Why the Broadcom bid for Qualcomm may end in a proxy battle

2017-08-31 16:37:34 | A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers

2017-07-27 14:43:02 | 4 Things To Know Before Trading A Leveraged ETF

2017-07-13 11:00:00 | This Market Action Is Once Again Sluggish

2017-06-30 11:38:00 | Fourth of July Fireworks May Be at Hand, but Today's Action Is a Dud

2017-06-28 10:45:00 | The Market Is Going Green, Yet Again

2017-02-17 13:40:00 | Biotech 2017: 4 Ideas for A Stockpicker's Year

2017-01-11 15:14:51 | What pharma investors ought to do after Donald Trump fires a salvo

2017-01-02 01:00:00 | NVDA, LABD, TWM: Rev Shark's Views

2016-12-28 11:24:00 | Dip Buying Wanes at Year's End

2016-12-08 10:34:26 | How Will Trump’s Take on the ACA Affect Healthcare Stocks?

2016-11-08 09:34:54 | Which Sectors to Invest in If Donald Trump Wins

2016-10-17 10:10:02 | ETFs to Play as Biotech Juggles Election & Earnings

2016-10-14 15:26:44 | Can Biotech Stocks Stay “Trendy”?

2016-09-29 14:00:00 | LABD Rallies as Mylan, Biotechs Slump LABD

2016-09-27 15:21:50 | Loving LABU: A Leveraged Biotech ETF On A Torrid Pace

2016-09-06 10:43:03 | Technicals, Politics Clash for Biotech ETFs

2016-08-25 14:14:58 | Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks

2016-08-25 06:52:48 | The Active Traders Guide To Hillary Clinton's Rhetoric

2016-08-04 13:46:57 | Biotech Rally Stokes Activity In Leveraged ETFs

2016-06-22 14:07:45 | Traders Get It Right Sort Of With Leveraged Biotech ETFs

2016-06-09 10:06:02 | Will New SEC Rules Hurt Triple Leveraged ETFs?

2016-06-07 00:33:52 | Biotech Bounce: Sizzle Or Fizzle?

2016-06-03 12:05:00 | How to Play the Biotech Rally IBB,GILD,LABD

2016-06-01 08:30:23 | Finally A Biotech ETF Bounce?

2016-05-16 08:00:35 | Resisting the Temptation of Biotech ETFs

2016-04-01 09:59:01 | Are These ETFs Making You An April Fool?

2016-02-29 13:45:00 | Top 10 ETFs Of 2016 To Date

2016-02-12 08:11:04 | This Little Nugget Of An ETF Is Delivering Astounding Returns

2016-02-11 13:43:34 | This Biotech ETF Is Setting A Blistering Pace

2016-02-11 10:33:00 | Barely Legal ETFs Bring Triple the Returns for China Bears

2016-01-20 16:28:13 | One Russia ETF To Look At Right Now

2016-01-12 09:30:02 | The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear

LABD motifs

There is no motif for this symbol